Drugs
Recent research published in the journal Cancer Chemotherapy and Pharmacology has made a significant breakthrough in understanding the cytotoxic mechanisms of compound 1, a diarylheptanoid isolated from Alpinia officinarum. The study, conducted by researchers at Harvard University, has shown that compound 1 induces S phase arrest and apoptosis in neuroblastoma
Drugs
South Korean researchers have made a significant discovery in understanding the molecular mechanisms induced by capsaicin and dihydrocapsaicin, two compounds found in chili peppers. The study, published in the Journal of Pharmacology and Experimental Therapeutics, reveals that these chemicals can cause cell survival or death, depending on the type of
Drugs
Researchers from LEO Pharma's Department of Pharmacology in Ballerup, Denmark, have published a study in the Journal of Investigative Dermatology, detailing the crucial role of regulatory T cells in controlling vascular endothelial growth factor (VEGF)-dependent skin inflammation. The study's findings reveal that a single injection
Drugs
Scientists in Copenhagen, Denmark, have made significant progress in understanding the mechanism of action of gamma-Hydroxybutyric acid (GHB), a proposed neurotransmitter or neuromodulator. Researchers at the University of Copenhagen have developed a novel compound, gamma-hydroxyfenbufen, which binds to GHB sites with 10-fold higher affinity than GHB itself. This breakthrough discovery
Drugs
A study in mice by researchers at the University of California, San Diego has found that the protein kinase JNK1 is crucial in the development of retinopathy in premature infants. The finding, published in the Proceedings of the National Academy of Sciences (PNAS), suggests that JNK1 inhibitors may lead to
Drugs
Breast cancer cells have been found to express high levels of choline kinase, which is associated with malignant transformation, invasion, and metastasis. Recent research has led to the development of novel pharmacologic or gene therapeutic interventions for ChoK-targeted inhibition. A study published in the journal Neoplasia investigated the uptake and
Drugs
In a groundbreaking study published in the Annals of Oncology, researchers from Saitama Medical University in Japan have made significant findings on the safety and tolerability of oral TAS-108 in postmenopausal patients with metastatic breast cancer. The study involved 15 patients who received TAS-108 treatment, with five patients receiving each
Drugs
Scientists at the University of São Paulo have made significant progress in the development of a novel anticancer agent, discodermolide. This natural product, which has the same mechanism of action as taxanes, demonstrates superior antitumor efficacy and therapeutic index. Researchers employed a fragment-based method to develop robust quantitative structure-activity relationship
Drugs
Researchers in Tokyo, Japan, have conducted a Phase I pharmacokinetic study to determine the maximum-tolerated dose (MTD) and recommended dose (RD) of paclitaxel (PTX) combined with S-1 for advanced gastric cancer patients. The study involved nine patients with peritoneal dissemination and/or cancer cells on peritoneal cytology, who received a
Drugs
Research findings suggest that a new approach to evaluating cancer treatments may be more effective. In a report published in the Journal of Biopharmaceutical Statistics, scientists describe a design for Phase II clinical trials to assess both response and stable disease rates in patients with cancer. This approach could lead
Drugs
Scientists at Vanderbilt University have discovered that diabetic patients treated with inhaled insulin exhibit reduced fasting plasma glucose levels, a finding that was confirmed in a study involving dogs. The researchers administered human insulin via inhalation or infusion to dogs, observing that glucose utilization was greater when insulin was administered
Drugs
Researchers in the United States have identified a synthetic compound, BEPP, that induces PKR-dependent apoptosis in sensitive cells and inhibits viral replication. BEPP was found to induce apoptosis with activation of caspase-3 and increase phosphorylation of PKR and eIF2 alpha. The compound was also effective in inhibiting the growth of
